Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 20, 2020CancersOpen Access

JAK-STAT Signalling Pathway in Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAndrew J. BrooksThe University of QueenslandTPTracy L. PutoczkiThe University of Melbourne

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Brooks et al. (2020) studied this question.

synapsesocial.com/papers/69fc0a760bc6a98b059c4d3ahttps://doi.org/10.3390/cancers12071971
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression2019 · 757 citations
  2. 2Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling2019 · 34 citations
  3. 3In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment2019 · 57 citations
  4. 4The PAK1-Stat3 Signaling Pathway Activates IL-6 Gene Transcription and Human Breast Cancer Stem Cell Formation2019 · 62 citations
  5. 5STAT3 Inhibits CD103+ cDC1 Vaccine Efficacy in Murine Breast Cancer2020 · 23 citations